Chitosan nanoparticles as delivery systems for doxorubicin.
By Kevin A. Janes, Marie P. Fresneau, Ana Marazuela, A. Fabra, M. J. Alonso. Journal of Controlled Release, 2001
708 citations recorded by the source corpus.
Subfields: Biomaterials, Pharmaceutical Science
View Paper: https://www.semanticscholar.org/paper/97f1639564051c7f8b4b35207e1cf4d2224fd49f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomaterials
- E. Chiellini
- A. Ribeiro
- Catarina P. Reis
- R. Ottenbrite
- Federica Chiellini
- F. Veiga
- R. Neufeld
- M. Dash
In Pharmaceutical Science
- E. Chiellini
- A. Ribeiro
- Catarina P. Reis
- R. Ottenbrite
- Federica Chiellini
- F. Veiga
- R. Neufeld
- M. Dash
Citations in the corpus
- Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. (2006, background): “Chitosan nanoparticles have been developed to encapsulated proteins such as bovine serum albumin, tetanus and diphtheria toxoid [6], vaccines [97], anticancer agents [98], insulin [99], and nucleic acids [100,101].”
- Chitosan—A versatile semi-synthetic polymer in biomedical applications (2011, background): “A complex of doxorubicin with chitosan was studied; where is was observed that complexes enter cells through an endocytotic mechanisms which was not further elucidated [95].”